|
ATE381542T1
(de)
*
|
2001-08-13 |
2008-01-15 |
Phenex Pharmaceuticals Ag |
Nr1h4-kern-rezeptor-bindende verbindungen
|
|
US6953787B2
(en)
|
2002-04-12 |
2005-10-11 |
Arena Pharmaceuticals, Inc. |
5HT2C receptor modulators
|
|
BR0311970A
(pt)
|
2002-06-19 |
2005-03-29 |
Biovitrum Ab |
Novos compostos, seu uso e preparação
|
|
US7105526B2
(en)
|
2002-06-28 |
2006-09-12 |
Banyu Pharmaceuticals Co., Ltd. |
Benzimidazole derivatives
|
|
TW200504033A
(en)
*
|
2002-10-23 |
2005-02-01 |
Procter & Gamble |
Melanocortin receptor ligands
|
|
KR100547109B1
(ko)
*
|
2002-11-14 |
2006-01-26 |
삼성전자주식회사 |
자외선 흡수 치환기를 포함한 기능성 첨가제 및 이를포함하는잉크 조성물
|
|
US7772188B2
(en)
|
2003-01-28 |
2010-08-10 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
|
CL2004000826A1
(es)
|
2003-04-25 |
2005-03-04 |
Pfizer |
Uso de un agonista para el receptor 5-ht2c para preparar un medicamento util en el tratamiento de la incontinencia urinaria provocada por estres, con la condicion de que el agonista no sea 1-[6-cloro-5-(trifluorometil)-2-piridinil]piperazina (org-129
|
|
SI2332921T1
(sl)
|
2003-06-17 |
2016-06-30 |
Arena Pharmaceuticals, Inc. |
8-kloro-1-metil-2,3,4,5-tetrahidro-1H-3-benzazapin hidroklorid
|
|
US7704993B2
(en)
|
2003-06-17 |
2010-04-27 |
Arena Pharmaceuticals, Inc. |
Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases
|
|
AU2004265243A1
(en)
*
|
2003-06-20 |
2005-02-24 |
Arena Pharmaceuticals, Inc. |
N-phenyl-piperazine derivatives and methods of prophylaxis or treatment of 5HT2c receptor associated diseases
|
|
WO2005028438A1
(ja)
|
2003-09-22 |
2005-03-31 |
Banyu Pharmaceutical Co., Ltd. |
新規ピペリジン誘導体
|
|
EP1734963A4
(en)
|
2004-04-02 |
2008-06-18 |
Merck & Co Inc |
METHOD FOR TREATING PEOPLE WITH METABOLIC AND ANTHROPOMETRIC DISORDER
|
|
EP1586560A1
(en)
*
|
2004-04-13 |
2005-10-19 |
Cephalon, Inc. |
Thio-substituted arylmethanesulfinyl derivatives
|
|
US7297817B2
(en)
*
|
2004-04-13 |
2007-11-20 |
Cephalon France |
Thio-substituted arylmethanesulfinyl derivatives
|
|
US8685924B2
(en)
|
2004-08-25 |
2014-04-01 |
Takeda Pharmaceutical Company Limited |
Preventives/remedies for stress urinary incontinence and method of screening the same
|
|
ES2325773T5
(es)
|
2004-11-01 |
2014-02-24 |
Amylin Pharmaceuticals, Llc. |
Tratamiento de la obesidad y de los trastornos relacionados
|
|
GT200500317A
(es)
*
|
2004-11-05 |
2006-10-27 |
|
Proceso para preparar compuestos de quinolina y productos obtenidos de los mismos
|
|
WO2006062110A1
(ja)
*
|
2004-12-06 |
2006-06-15 |
Banyu Pharmaceutical Co., Ltd. |
ピペラジン誘導体
|
|
WO2006064780A1
(ja)
*
|
2004-12-14 |
2006-06-22 |
Shionogi & Co., Ltd. |
便秘治療剤
|
|
CA2589988C
(en)
|
2004-12-21 |
2017-02-14 |
Arena Pharmaceuticals, Inc. |
Crystalline forms of (r)-8-chloro-1-methyl- 2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride
|
|
US20090286723A1
(en)
|
2005-02-11 |
2009-11-19 |
Amylin Pharmaceuticals, Inc. |
Hybrid Polypeptides with Selectable Properties
|
|
US7737155B2
(en)
|
2005-05-17 |
2010-06-15 |
Schering Corporation |
Nitrogen-containing heterocyclic compounds and methods of use thereof
|
|
NZ562766A
(en)
|
2005-05-30 |
2011-03-31 |
Banyu Pharma Co Ltd |
Piperidine derivatives as histamine-H3 receptor antagonists
|
|
AR054849A1
(es)
*
|
2005-07-26 |
2007-07-18 |
Wyeth Corp |
Diazepinoquinolinas, sintesis de las mismas, e intermediarios para obtenerlas
|
|
EP1916239A4
(en)
|
2005-08-10 |
2009-10-21 |
Banyu Pharma Co Ltd |
PYRIDOLVERBINDUNG
|
|
BRPI0614649A2
(pt)
|
2005-08-11 |
2011-04-12 |
Amylin Pharmaceuticals Inc |
polipeptìdeos hìbridos com propriedades selecionáveis
|
|
AU2006282260A1
(en)
|
2005-08-24 |
2007-03-01 |
Msd K.K. |
Phenylpyridone derivative
|
|
US20090264426A1
(en)
|
2005-09-07 |
2009-10-22 |
Shunji Sakuraba |
Bicyclic aromatic substituted pyridone derivative
|
|
US8293900B2
(en)
|
2005-09-29 |
2012-10-23 |
Merck Sharp & Dohme Corp |
Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
|
|
US20080255084A1
(en)
|
2005-10-21 |
2008-10-16 |
Randy Lee Webb |
Combination of Organic Compounds
|
|
EP1944301A4
(en)
|
2005-10-27 |
2012-01-04 |
Msd Kk |
NEW BENZOXATHIIN DERIVATIVES
|
|
CA2629018C
(en)
|
2005-11-10 |
2013-12-31 |
Banyu Pharmaceutical Co., Ltd. |
Aza-substituted spiro derivative
|
|
TW200734334A
(en)
*
|
2006-01-13 |
2007-09-16 |
Wyeth Corp |
Treatment of substance abuse
|
|
TW200806300A
(en)
*
|
2006-03-24 |
2008-02-01 |
Wyeth Corp |
New therapeutic combinations for the treatment of depression
|
|
EP2518053A1
(en)
|
2006-04-03 |
2012-10-31 |
Arena Pharmaceuticals, Inc. |
Process for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine
|
|
EP2018863B9
(en)
|
2006-05-16 |
2015-02-18 |
Takeda Pharmaceutical Company Limited |
Fused heterocyclic compound and use thereof
|
|
EP2698157B1
(en)
|
2006-09-22 |
2015-05-20 |
Merck Sharp & Dohme Corp. |
Method of treatment using fatty acid synthesis inhibitors
|
|
WO2008038692A1
(en)
|
2006-09-28 |
2008-04-03 |
Banyu Pharmaceutical Co., Ltd. |
Diaryl ketimine derivative
|
|
EP2099743B1
(en)
|
2006-12-05 |
2014-08-27 |
Arena Pharmaceuticals, Inc. |
Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates thereof
|
|
CN101631859B
(zh)
|
2007-01-16 |
2017-10-13 |
Ipintl有限责任公司 |
用于治疗代谢综合征的新组合物
|
|
US8106086B2
(en)
|
2007-04-02 |
2012-01-31 |
Msd K.K. |
Indoledione derivative
|
|
WO2008140197A1
(en)
|
2007-05-14 |
2008-11-20 |
Sk Holdings Co., Ltd. |
Novel carbamoyloxy aryl alkan arylpiperazine compound, pharmaceutical compositions comprising the compound and method for treating pain, anxiety and depression by administering the compound
|
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
|
MX354786B
(es)
|
2007-06-04 |
2018-03-21 |
Synergy Pharmaceuticals Inc |
Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
|
|
CL2008002777A1
(es)
*
|
2007-09-21 |
2010-01-22 |
Wyeth Corp |
Metodo de preparacion de compuestos diazepinoquinolinicos quirales por recristalizacion en un sistema de solvente ternario.
|
|
EP2789338A3
(en)
|
2007-11-15 |
2015-01-14 |
Takeda Pharmaceutical Company Limited |
Condensed pyridine derivate and use thereof
|
|
US8093248B2
(en)
|
2007-12-05 |
2012-01-10 |
Astrazeneca Ab (Publ) |
Compounds useful for the treatment of conditions associated with weight gain
|
|
JP5491421B2
(ja)
|
2008-03-04 |
2014-05-14 |
アリーナ ファーマシューティカルズ， インコーポレイテッド |
５−ｈｔ２ｃアゴニストである（ｒ）−８−クロロ−１−メチル−２，３，４，５−テトラヒドロ−１ｈ−３−ベンゾアゼピンに関連する中間体の調製のためのプロセス
|
|
EP2264026A4
(en)
|
2008-03-06 |
2012-03-28 |
Msd Kk |
ALKYLAMINOPYRIDINDERIVATE
|
|
JPWO2009119726A1
(ja)
|
2008-03-28 |
2011-07-28 |
Ｍｓｄ株式会社 |
メラニン凝集ホルモン受容体拮抗作用を有するジアリールメチルアミド誘導体
|
|
CA2666036C
(en)
|
2008-05-16 |
2017-09-12 |
Chien-Hung Chen |
Novel compositions and methods for treating hyperproliferative diseases
|
|
JP2011522006A
(ja)
*
|
2008-06-04 |
2011-07-28 |
アストラゼネカ アクチボラグ |
新規化合物ｖ
|
|
CA2726917C
(en)
|
2008-06-04 |
2018-06-26 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
|
US20110071129A1
(en)
|
2008-06-19 |
2011-03-24 |
Makoto Ando |
Spirodiamine-diaryl ketoxime derivative
|
|
EP2321341B1
(en)
|
2008-07-16 |
2017-02-22 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
|
|
WO2010013595A1
(ja)
|
2008-07-30 |
2010-02-04 |
萬有製薬株式会社 |
５員－５員又は５員－６員縮環シクロアルキルアミン誘導体
|
|
US8410284B2
(en)
|
2008-10-22 |
2013-04-02 |
Merck Sharp & Dohme Corp |
Cyclic benzimidazole derivatives useful as anti-diabetic agents
|
|
MX2011004551A
(es)
|
2008-10-30 |
2011-05-25 |
Merck Sharp & Dohme |
Antagonistas del receptor de orexina de isonicotinamida.
|
|
CA2741672A1
(en)
|
2008-10-31 |
2010-05-06 |
Merck Sharp & Dohme Corp. |
Novel cyclic benzimidazole derivatives useful anti-diabetic agents
|
|
WO2010075069A1
(en)
|
2008-12-16 |
2010-07-01 |
Schering Corporation |
Bicyclic pyranone derivatives as nicotinic acid receptor agonists
|
|
EP2379547A1
(en)
|
2008-12-16 |
2011-10-26 |
Schering Corporation |
Pyridopyrimidine derivatives and methods of use thereof
|
|
CN102648170A
(zh)
|
2009-06-18 |
2012-08-22 |
艾尼纳制药公司 |
制备5-ht2c受体激动剂的方法
|
|
US20120253036A1
(en)
|
2009-12-11 |
2012-10-04 |
Yukinori Nagakura |
Agent for treating fibromyalgia
|
|
AU2011218830B2
(en)
|
2010-02-25 |
2014-07-24 |
Merck Sharp & Dohme Corp. |
Novel cyclic benzimidazole derivatives useful anti-diabetic agents
|
|
WO2011153206A1
(en)
|
2010-06-02 |
2011-12-08 |
Arena Pharmaceuticals, Inc. |
Processes for the preparation of 5-ht2c receptor agonists
|
|
KR20180118801A
(ko)
|
2010-09-01 |
2018-10-31 |
에자이 알앤드디 매니지먼트 가부시키가이샤 |
체중 관리에 유용한 5-ｈｔ2ｃ 작동제의 변형-방출 투여 형태
|
|
MX2013002422A
(es)
|
2010-09-01 |
2013-05-17 |
Arena Pharm Inc |
Sales de lorcaserina con acidos opticamente activos.
|
|
CN103347523A
(zh)
|
2010-09-01 |
2013-10-09 |
艾尼纳制药公司 |
向具有肾损伤的个体给药氯卡色林
|
|
WO2012030957A2
(en)
|
2010-09-01 |
2012-03-08 |
Arena Pharmaceuticals, Inc. |
Non-hygroscopic salts of 5-ht2c agonists
|
|
US9616097B2
(en)
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
|
CA2813189C
(en)
*
|
2010-09-29 |
2020-04-28 |
Sk Biopharmaceuticals Co., Ltd. |
Novel methylcyclohexane derivatives and uses thereof
|
|
CA2826649C
(en)
|
2011-02-25 |
2016-07-26 |
Merck Sharp & Dohme Corp. |
Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents
|
|
EA201391254A1
(ru)
|
2011-03-01 |
2014-02-28 |
Синерджи Фармасьютикалз Инк. |
Способ получения агонистов гуанилатциклазы c
|
|
AR088352A1
(es)
|
2011-10-19 |
2014-05-28 |
Merck Sharp & Dohme |
Antagonistas del receptor de 2-piridiloxi-4-nitrilo orexina
|
|
RU2015106909A
(ru)
|
2012-08-02 |
2016-09-27 |
Мерк Шарп И Доум Корп. |
Антидиабетические трициклические соединения
|
|
WO2014058441A1
(en)
|
2012-10-09 |
2014-04-17 |
Arena Pharmaceuticals, Inc. |
Method of weight management
|
|
EP2970119B1
(en)
|
2013-03-14 |
2021-11-03 |
Merck Sharp & Dohme Corp. |
Novel indole derivatives useful as anti-diabetic agents
|
|
WO2014151200A2
(en)
|
2013-03-15 |
2014-09-25 |
Synergy Pharmaceuticals Inc. |
Compositions useful for the treatment of gastrointestinal disorders
|
|
JP2016514671A
(ja)
|
2013-03-15 |
2016-05-23 |
シナジー ファーマシューティカルズ インコーポレイテッド |
グアニル酸シクラーゼのアゴニストおよびその使用
|
|
CN103265498A
(zh)
*
|
2013-05-14 |
2013-08-28 |
广州科瑞生物技术有限公司 |
反式2,6-二甲基哌嗪的新工艺
|
|
CN105764916B
(zh)
|
2013-06-05 |
2021-05-18 |
博士医疗爱尔兰有限公司 |
鸟苷酸环化酶c的超纯激动剂、制备和使用所述激动剂的方法
|
|
WO2015066344A1
(en)
|
2013-11-01 |
2015-05-07 |
Arena Pharmaceuticals, Inc. |
5-ht2c receptor agonists and compositions and methods of use
|
|
MX389591B
(es)
|
2014-08-29 |
2025-03-20 |
Tes Pharma S R L |
INHIBIDORES DE ACIDO A-AMINO-ß-CARBOXIMUCONICO SEMIALDEHIDO DESCARBOXILASA
|
|
MX2019004321A
(es)
|
2016-10-14 |
2019-06-12 |
Tes Pharma S R L |
Inhibidores de la acido alfa-amino-beta-carboximuconico semialdehido descarboxilasa.
|
|
US20210052600A1
(en)
|
2017-12-27 |
2021-02-25 |
Takeda Pharmaceutical Company Limited |
Therapeutic agents for stress urinary incontinence and incotinence of feces
|
|
CN118496217A
(zh)
|
2018-11-20 |
2024-08-16 |
Tes制药有限责任公司 |
α-氨基-β-羧基己二烯二酸半醛去羧酶的抑制剂
|
|
US12331018B2
(en)
|
2019-02-13 |
2025-06-17 |
Merck Sharp & Dohme Llc |
Pyrrolidine orexin receptor agonists
|
|
EP3924058B1
(en)
|
2019-02-13 |
2026-01-07 |
Merck Sharp & Dohme LLC |
5-alkyl pyrrolidine orexin receptor agonists
|
|
US12312332B2
(en)
|
2019-08-08 |
2025-05-27 |
Merck Sharp & Dohme Llc |
Heteroaryl pyrrolidine and piperidine orexin receptor agonists
|
|
CN111646949B
(zh)
*
|
2020-06-12 |
2021-03-30 |
上海馨远医药科技有限公司 |
一种2,6-二甲基哌嗪二盐酸盐的制备方法
|
|
US20230365533A1
(en)
|
2020-08-18 |
2023-11-16 |
Merck Sharp & Dohme Llc |
Bicycloheptane pyrrolidine orexin receptor agonists
|